U.S. Metals and Mining Stock News

NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

AutoKinex In‑Vehicle Virtual Agent Launch Could Be A Game Changer For Verra Mobility (VRRM)

Verra Mobility Corporation has launched its AutoKinex™ Virtual Agent, allowing rental car customers to complete checkout and manage add-on services directly from the vehicle’s infotainment system, shifting traditionally counter-based tasks into the car to streamline operations and improve the rental experience. By embedding guided, in-vehicle workflows that integrate with existing rental systems, the AutoKinex™ Virtual Agent could meaningfully change how rental fleets monetize services such...
NasdaqCM:NUCL
NasdaqCM:NUCLOil and Gas

A Look At Eagle Nuclear Energy (NUCL) Valuation As Aurora Permitting Progress Advances

Permitting progress at Aurora puts Eagle Nuclear Energy (NUCL) in focus Eagle Nuclear Energy (NUCL) drew fresh attention after its permitting manager submitted drill program applications for the Aurora project to U.S. federal and Oregon regulators, with both agencies confirming receipt. The company plans to start a PFS-related summer drill campaign, supported by BBA and Harris Drilling, while also preparing a multifaceted environmental baseline program that ties Aurora to its broader uranium...
NasdaqGS:MMED
NasdaqGS:MMEDMedical Equipment

MiniMed Group (MMED) Q3 Loss Undercuts Bullish Profitability Narrative Despite Revenue Base

MiniMed Group (NasdaqGS:MMED) has released its Q3 2026 results, reporting quarterly revenue of US$737.5 million and a net income loss of US$14.5 million, while the share price trades around US$14.44. Over the past few reported periods, the company’s quarterly revenue has moved from US$652 million in early 2025 to US$737.5 million in early 2026, with net income losses narrowing from US$15.5 million to US$14.5 million. This frames a narrative centered on how efficiently that top line can be...
OTCPK:UBOH
OTCPK:UBOHBanks

United Bancshares (OTCPK:UBOH) Net Interest Margin Expansion Challenges Cautious Narratives

United Bancshares (UBOH) opened 2026 with Q4 2025 revenue of US$12.6 million and basic EPS of US$1.04, with trailing twelve month revenue at US$47.0 million and EPS at US$4.04 as the latest benchmark for earnings power. Over the past year, revenue has moved from US$41.8 million to US$47.0 million and basic EPS from US$3.06 to US$4.04, while the net profit margin on a trailing basis sits at 25.5% compared with 21.9% a year earlier, indicating a period where profitability expanded faster than...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf Index Additions Align With Strong Momentum And Valuation Upside

Diebold Nixdorf (NYSE:DBD) has been added to the S&P 600, S&P 1000, and S&P Composite 1500 indices. The index changes elevate the company’s visibility with institutional and index-tracking investors. The additions follow a period of strong share price performance and come with NYSE:DBD recently closing at $88.77. For investors watching NYSE:DBD, the index inclusions come after a sharp share price move, with the stock up 4.7% over the past week and 24.2% over the past month. The gain stands...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

Is GE HealthCare Technologies (GEHC) Attractive After 9.9% Year-To-Date Share Price Decline?

If you are wondering whether GE HealthCare Technologies is attractively priced or starting to look stretched, the current setup offers plenty for valuation focused investors to unpack. The stock last closed at US$74.66, with returns of 2.0% over 7 days, 7.2% over 30 days, a 9.9% decline year to date, and a 20.0% gain over 1 year, which gives a mixed picture of recent performance. Recent coverage has centered on GE HealthCare Technologies as a standalone medical technology player following...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Lagging EPS And ROE Versus Peers Might Change The Case For Investing In Selective (SIGI)

Recently, a critical article highlighted that Selective Insurance Group’s earnings per share and book value growth have trailed peers, raising questions about management’s capital allocation and return on equity compared with other insurers. This negative analyst commentary has drawn attention to the gap between Selective’s current performance metrics and those of its industry rivals, putting management’s execution under closer investor scrutiny. Now we’ll examine how concerns over lagging...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Astronics Qi2 Wireless Charging Launch Tests Cabin Power Growth Story

Astronics (NasdaqGS:ATRO) has introduced its new EmPower Qi2 Wireless Charging Module for aircraft cabins, galleys, and crew rest areas. The module supports the latest Qi enabled and MagSafe compatible devices and is designed for rapid maintenance and compliance with aviation standards. Astronics focuses on aerospace and defense electronics, with cabin power and connectivity as a core part of its business. The EmPower Qi2 Wireless Charging Module fits directly into that franchise and aims...
NasdaqGS:AKTS
NasdaqGS:AKTSBiotechs

Aktis Oncology Board Shift And New Committee Draw Investor Focus On R&D

Aktis Oncology (NasdaqGS: AKTS) has appointed Dr. Glenn Gormley as an independent director to its Board. Dr. Gormley will also serve as co-chair of a newly formed Science and Technology Committee. The company announced upcoming departures of two current Board members as part of this transition. Aktis Oncology, trading on NasdaqGS under the ticker AKTS, recently closed at $20.25. The stock is up 20.0% over the past week and 14.4% over the past 30 days, while the year-to-date return stands at...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Is It Too Late To Consider Cohu (COHU) After A 193% One Year Surge?

If you are wondering whether Cohu at around US$41.26 is still reasonably priced after a strong run, this article walks through what the current numbers say about value. The stock has posted returns of 10.5% over the last 7 days, 39.8% over 30 days, 67.7% year to date, and 193.5% over 1 year, which has put valuation firmly in focus for many investors. Recent coverage has highlighted Cohu's position within the semiconductor space and how sentiment around the industry has influenced stocks with...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Ally Earnings Jump Raises Questions On Dividend Strength And Auto Risk

Ally Financial (NYSE:ALLY) reported first quarter results featuring a 90% jump in adjusted EPS, record origination volumes, and strong digital banking growth. The company highlighted progress on its Focus Forward transformation, with higher auto loan activity and digital engagement contributing to the quarter. These developments come after prior business divestitures, as Ally continues to concentrate on core auto finance and digital banking operations. For investors tracking NYSE:ALLY, the...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

Regulatory Case Resolved For PDD Holdings As Valuation Gap Persists

PDD Holdings (NasdaqGS:PDD) has reached a resolution to a major regulatory investigation in China. As part of the conclusion, authorities imposed a fine on the company, closing out a significant enforcement action. The outcome removes a key source of uncertainty that had been hanging over PDD Holdings. PDD Holdings, the owner of e commerce platform Pinduoduo and cross border marketplace Temu, operates at the center of China’s large online retail and discount shopping market. The company...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

Is It Too Late To Consider Limbach Holdings (LMB) After Strong Multi Year Share Price Gains

If you are wondering whether Limbach Holdings at around US$93.56 is offering good value or stretching expectations, you are not alone. The stock has posted returns of 13.3% over the last 7 days, 32.7% over 30 days, 18.3% year to date, 8.0% over 1 year and a very large gain over 5 years, which naturally raises questions about what is already priced in and how much risk you are taking on at current levels. Recent coverage has focused on Limbach Holdings as investors reassess contractors and...
NasdaqGS:VSAT
NasdaqGS:VSATCommunications

Is It Too Late To Consider Viasat (VSAT) After A 7x One Year Surge?

If you are wondering whether Viasat’s share price still offers value after a strong run, it helps to step back and look at what the current market price might be implying about the business. Viasat last closed at US$62.85, with returns of 11.7% over the past 7 days, 35.5% over the past 30 days, 67.0% year to date, and a very large gain over the last year, with the 1-year return around 7x. Recent headlines around Viasat have focused on its role in satellite communications, large contracts,...
NYSE:RVTY
NYSE:RVTYLife Sciences

The Bull Case For Revvity (RVTY) Could Change Following Its New AI-Enabled Oncology Platform Push

In April 2026, Revvity, Inc. showcased a suite of research-use-only oncology tools at the AACR Annual Meeting and introduced its cloud-native Signals BioDesign molecular cloning software at Bio-IT World, highlighting integrated instruments, reagents, and AI-enabled analytics aimed at streamlining cancer and biologics research workflows. By linking advanced imaging, automation, and cloud software within unified research ecosystems, Revvity is positioning its oncology and biologics platforms...
NYSE:NEU
NYSE:NEUChemicals

Is NewMarket (NEU) Still Attractive After Recent Pullback And DCF Upside Signal

If you are wondering whether NewMarket at around US$634 per share still offers fair value or is starting to look stretched, the key is to understand what the current price actually reflects. The stock has seen mixed recent returns, with 0.9% over the last week, 3.2% over the past month, a 7.8% decline year to date, and 14.4% over the last year, alongside very large gains over 3 and 5 years. Recent coverage has focused on NewMarket's position in the Chemicals sector and how its longer term...
NYSE:PNC
NYSE:PNCBanks

PNC’s FirstBank Deal Expands Colorado Presence And Fuels Loan Growth

PNC Financial Services Group (NYSE:PNC) announced the acquisition of FirstBank, expanding its footprint in Colorado. The deal added substantial loans and deposits to PNC’s balance sheet and supported record organic loan growth. PNC introduced new executive leadership to oversee the private banking segment in the expanded Colorado region. For investors watching regional banks, PNC Financial Services Group sits among the large, diversified U.S. players with a mix of retail, commercial, and...
NYSE:ESE
NYSE:ESEMachinery

ESCO Technologies Megger Deal Expands Grid Reliability And Earnings Story

ESCO Technologies (NYSE:ESE) announced the acquisition and planned merger of Megger Group, a global provider of electrical testing and utility solutions. The combination brings together two established players in grid reliability, predictive maintenance, and utility diagnostics. The deal is structured to broaden ESCO's portfolio, with a focus on operational resilience and expanded service capabilities for utilities worldwide. ESCO Technologies, trading at $314.92, has seen very strong...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

APA Production Cut Links Waha Gas Prices To Valuation Opportunity

APA Corporation curtailed a significant amount of U.S. natural gas and NGL production in Q1 2026. The decision was driven by unfavorable Waha hub pricing for natural gas. The move reflects an operational adjustment that could affect revenue and production guidance. For investors, this production cut comes with APA shares at $35.74, after a 40.9% gain year to date and a 133.3% return over the past year. Those figures sit alongside weaker recent trading, with a 7.5% decline over the past week...
NasdaqGM:HIFS
NasdaqGM:HIFSBanks

Hingham Institution For Savings (HIFS) Q1 2026 Net Interest Margin Improvement Tests Bearish Narratives

Hingham Institution for Savings (HIFS) has released its Q1 2026 scorecard, reporting total revenue of US$12.0 million, basic EPS of US$1.30 and net income of US$2.85 million, setting the tone for this reporting period. Over the last year, revenue has moved from US$65.5 million in Q4 2024 to US$102.8 million on a trailing twelve month basis. Over the same period, trailing EPS has increased from US$12.95 to US$23.04, giving investors a clearer view of how the earnings base has shifted ahead of...
NYSE:TNET
NYSE:TNETProfessional Services

Is It Time To Reconsider TriNet Group (TNET) After A 48% One Year Share Price Slide

If you are wondering whether TriNet Group's current share price lines up with its fundamentals, the valuation picture is where things start to get interesting. The stock last closed at US$38.77, with returns of 12.0% over the past week and 2.5% over the past month, set against a return of 32.2% decline year to date and 48.2% decline over the past year. Recent headlines around TriNet Group have focused on broader market sentiment toward professional services companies and how investors are...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

ePlus’ AI-Era Memory Reclamation Push Might Change The Case For Investing In ePlus (PLUS)

Earlier in April 2026, ePlus announced a Memory Optimization and Reclamation Assessment aimed at helping enterprises reclaim underused memory capacity amid severe AI-driven memory chip shortages and supply chain constraints identified by Gartner. By focusing on uncovering “zombie” and stranded memory and providing an optimization roadmap with cost-avoidance insights, ePlus is positioning itself as a practical partner for customers struggling to secure or afford new memory hardware. Next,...
NasdaqGS:MPLT
NasdaqGS:MPLTBiotechs

A Look At MapLight Therapeutics (MPLT) Valuation After Its Sharp Recent Share Price Surge

MapLight Therapeutics (MPLT) has drawn attention after a sharp share price move over the past month, with the stock closing at US$30.05 and a market value around US$1.24b, inviting closer scrutiny from biotech investors. See our latest analysis for MapLight Therapeutics. The recent 76.6% 30 day share price return, and 79.2% year to date share price return, point to strong short term momentum that contrasts with MapLight Therapeutics’ early stage fundamentals and lack of reported revenue so...
NasdaqGS:COGT
NasdaqGS:COGTBiotechs

Is AACR 2026 KRAS and ErbB2 Data Altering The Investment Case For Cogent Biosciences (COGT)?

Cogent Biosciences recently announced that preclinical data from its KRAS and ErbB2 pipeline programs, including KRAS(ON) inhibitor CGT1263 and brain-penetrant ErbB2 inhibitor CGT4255, were presented at the AACR Annual Meeting 2026 in San Diego. The data highlight highly selective targeting and promising antitumor activity with potentially improved tolerability and central nervous system reach, features that could meaningfully differentiate these candidates from existing approaches if future...